Study of a New Intravenous Drug, Called S65487, in Patients With Acute Myeloid Leukemia, Non Hodgkin Lymphoma, Multiple Myeloma or Chronic Lymphocytic Leukemia
PHASE1
The purpose of this first in human study is to assess safety, tolerability,...
Status
Terminated
Location
The Alfred Hospital Malignant Haematology & Stem Cell Transplantation Services
A Multi-Site Break Through Cancer Trial: Targeting Measurable Residual Disease in Patients With Acute Myeloid Leukemia: A Phase 1/2 Study of Tagraxofusp, Azacitidine, and Venetoclax
PHASE1
The purpose of this research study is to test the safety and efficacy of a ...
A Study to Assess the Adverse Events and Change in Disease Activity in Adult Participants With Relapsed or Refractory Multiple Myeloma Receiving Oral ABBV-453 Tablets
PHASE1
Multiple myeloma (MM) is a plasma cell disease characterized by the growth ...